Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Abortive initiation is increased only for the weakest members of a set of down mutants of the adenovirus 2 major late promoter.

Class:Id	LiteratureReference:110396
_displayName	Abortive initiation is increased only for the weakest members of a set of down mutants of the adenovirus 2 major late promoter.
_timestamp	2011-07-22 15:51:04
author	[Person:111074] Jacob, GA [Person:111077] Luse, SW [Person:111073] Luse, DS
journal	J Biol Chem
modified	[InstanceEdit:1458674] D'Eustachio, P, 2011-07-22
pages	22537-44
pubMedIdentifier	1939271
title	Abortive initiation is increased only for the weakest members of a set of down mutants of the adenovirus 2 major late promoter.
volume	266
year	1991
(literatureReference)	[Reaction:73946] Abortive initiation after formation of the first phosphodiester bond [Homo sapiens] [Reaction:75856] Abortive Initiation Before Second Transition [Homo sapiens] [Reaction:75891] Abortive Initiation After Second Transition [Homo sapiens] [Reaction:167468] Abortive HIV-1 Initiation After Second Transition [Homo sapiens] [Reaction:167474] Abortive HIV-1 Initiation Before Second Transition [Homo sapiens] [Reaction:167477] Abortive HIV-1 initiation after formation of the first phosphodiester bond [Homo sapiens]
[Change default viewing format]

No pathways have been reviewed or authored by Abortive initiation is increased only for the weakest members of a set of down mutants of the adenovirus 2 major late promoter. (110396)